N-terminal pro-brain natriuretic peptide as a biomarker for differentiating cardiac and pulmonary disease in term neonates with respiratory distress.

J Saudi Heart Assoc · 2020 · PMC7640609 · PMID 33154894

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Comparison between the studied neonatal groups revealed that there was a highly significant difference between and within the three groups regarding the mean of NT-pro BNP (NT-pro BNP mean of CHD, PD, and control was 27.03 ± 5.28, 14.95 ± 2.72, and 8.07 ± 1.02, respectively; p = 0.001), i.e., NT-pro BNP was significantly higher in the CHD group than in the PD and control groups ( Fig. 2 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.